BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38625410)

  • 21. Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck.
    Subramaniam T; Lennon P; O'Neill JP
    Ir J Med Sci; 2015 Sep; 184(3):583-90. PubMed ID: 25894281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation.
    Ali S; Palmer FL; Katabi N; Lee N; Shah JP; Patel SG; Ganly I
    Laryngoscope; 2017 Oct; 127(10):2265-2269. PubMed ID: 28322454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenoid cystic carcinoma of the head and neck.
    Balamucki CJ; Amdur RJ; Werning JW; Vaysberg M; Morris CG; Kirwan JM; Mendenhall WM
    Am J Otolaryngol; 2012; 33(5):510-8. PubMed ID: 22226227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature.
    Bhattasali O; Holliday E; Kies MS; Hanna EY; Garden AS; Rosenthal DI; Morrison WH; Gunn GB; Fuller CD; Zhu XR; Frank SJ
    Head Neck; 2016 Apr; 38 Suppl 1():E1472-80. PubMed ID: 26561041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma.
    Song T; Chen P; Fang M; Zhang X; Du D; Wu S
    Cancer Manag Res; 2020; 12():1631-1639. PubMed ID: 32184666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
    Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
    Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of postoperative adjuvant radiotherapy and postoperative concurrent chemoradiotherapy for locally advanced hypopharyngeal squamous cell carcinoma].
    Liu K; Zhang XX; Liu MB; Wang JL; Wu WM; Huang DL; Zhao JD; Ma L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 54(9):662-669. PubMed ID: 31550757
    [No Abstract]   [Full Text] [Related]  

  • 30. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.
    Meyers M; Granger B; Herman P; Janot F; Garrel R; Fakhry N; Poissonnet G; Baujat B;
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):13-7. PubMed ID: 26493113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
    Nakahara S; Takenaka Y; Ogawa K; Nishiike S; Yamamoto Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Yoshii T; Tomiyama Y; Inohara H
    Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.
    Douglas JG; Laramore GE; Austin-Seymour M; Koh W; Stelzer K; Griffin TW
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):551-7. PubMed ID: 10701733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of adjuvant (chemo-)radiotherapy in oral cancers in the contemporary era.
    Huang SH; Hahn E; Chiosea SI; Xu ZY; Li JS; Shen L; O'Sullivan B
    Oral Oncol; 2020 Mar; 102():104563. PubMed ID: 31918174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study.
    Wang F; Zhou L; Zhang LJ; Xie CB; Liao ZW; Lin XD; Wen YF
    Radiother Oncol; 2024 Feb; 191():110081. PubMed ID: 38185256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant Therapy for Salivary Gland Carcinomas.
    Sayan M; Vempati P; Miles B; Teng M; Genden E; Demicco EG; Misiukiewicz K; Posner M; Gupta V; Bakst RL
    Anticancer Res; 2016 Aug; 36(8):4165-70. PubMed ID: 27466526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience.
    Ali S; Yeo JC; Magos T; Dickson M; Junor E
    J Laryngol Otol; 2016 Jul; 130(7):680-5. PubMed ID: 27268306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
    Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
    Tobias JS; Monson K; Gupta N; Macdougall H; Glaholm J; Hutchison I; Kadalayil L; Hackshaw A;
    Lancet Oncol; 2010 Jan; 11(1):66-74. PubMed ID: 19875337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoid cystic carcinoma of the head and neck: a retrospective multicenter study.
    Takebayashi S; Shinohara S; Tamaki H; Tateya I; Kitamura M; Mizuta M; Tanaka S; Kojima T; Asato R; Maetani T; Ushiro K; Kitani Y; Ichimaru K; Honda K; Yamada K; Omori K
    Acta Otolaryngol; 2018 Jan; 138(1):73-79. PubMed ID: 28899226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.